Birleşik Krallık - İngilizce - MHRA (Medicines & Healthcare Products Regulatory Agency)

forum health products ltd - potassium bicarbonate; sodium alginate - chewable tablet - 100mg ; 500mg

Yeni Zelanda - İngilizce - Ministry for Primary Industries

animal control products limited trading as orillion - sodium cyanide - sodium cyanide 550 g/kg - vertebrate toxic agent

Yeni Zelanda - İngilizce - Ministry for Primary Industries

animal control products limited trading as orillion - diphacinone - diphacinone 0.05 g/kg - vertebrate toxic agent

Avustralya - İngilizce - Department of Health (Therapeutic Goods Administration)

generic health pty ltd - lisinopril dihydrate, quantity: 21.78 mg (equivalent: lisinopril, qty 20 mg) - tablet, uncoated - excipient ingredients: maize starch; pregelatinised maize starch; iron oxide red; colloidal anhydrous silica; mannitol; magnesium stearate; calcium hydrogen phosphate dihydrate - hypertension. lisinopril generic health tablets are indicated in the treatment of hypertension. it may be used alone or concomitantly with other classes of antihypertensive agents. sufficient data have not been provided to support the use of lisinopril in severe hypertension or renovascular hypertension. congestive heart failure lisinopril generic health tablets are also indicated in the treatment of heart failure. in such patients, it is recommended that lisinopril generic health tablets be administered together with a diuretic. acute myocardial infarction: lisinopril generic health tablets are indicated for the treatment of acute myocardial infarction in haemodynamically stable patients, defined as patients who are not in cardiogenic shock and who have a systolic blood pressure greater than 100mmhg. lisinopril may be initiated within 24 hours of an acute myocardial infarction.

Avustralya - İngilizce - Department of Health (Therapeutic Goods Administration)

generic health pty ltd - lisinopril dihydrate, quantity: 10.89 mg (equivalent: lisinopril, qty 10 mg) - tablet, uncoated - excipient ingredients: magnesium stearate; iron oxide red; colloidal anhydrous silica; mannitol; maize starch; calcium hydrogen phosphate dihydrate; pregelatinised maize starch - hypertension. lisinopril generic health tablets are indicated in the treatment of hypertension. it may be used alone or concomitantly with other classes of antihypertensive agents. sufficient data have not been provided to support the use of lisinopril in severe hypertension or renovascular hypertension. congestive heart failure lisinopril generic health tablets are also indicated in the treatment of heart failure. in such patients, it is recommended that lisinopril generic health tablets be administered together with a diuretic. acute myocardial infarction: lisinopril generic health tablets are indicated for the treatment of acute myocardial infarction in haemodynamically stable patients, defined as patients who are not in cardiogenic shock and who have a systolic blood pressure greater than 100mmhg. lisinopril may be initiated within 24 hours of an acute myocardial infarction.

Avustralya - İngilizce - Department of Health (Therapeutic Goods Administration)

generic health pty ltd - lisinopril dihydrate, quantity: 5.44 mg (equivalent: lisinopril, qty 5 mg) - tablet, uncoated - excipient ingredients: iron oxide red; calcium hydrogen phosphate dihydrate; mannitol; pregelatinised maize starch; colloidal anhydrous silica; magnesium stearate; maize starch - hypertension. lisinopril generic health tablets are indicated in the treatment of hypertension. it may be used alone or concomitantly with other classes of antihypertensive agents. sufficient data have not been provided to support the use of lisinopril in severe hypertension or renovascular hypertension. congestive heart failure lisinopril generic health tablets are also indicated in the treatment of heart failure. in such patients, it is recommended that lisinopril generic health tablets be administered together with a diuretic. acute myocardial infarction: lisinopril generic health tablets are indicated for the treatment of acute myocardial infarction in haemodynamically stable patients, defined as patients who are not in cardiogenic shock and who have a systolic blood pressure greater than 100mmhg. lisinopril may be initiated within 24 hours of an acute myocardial infarction.

İrlanda - İngilizce - HPRA (Health Products Regulatory Authority)

accord healthcare ireland ltd. - aripiprazole - tablet - 10 milligram(s) - other antipsychotics; aripiprazole

İrlanda - İngilizce - HPRA (Health Products Regulatory Authority)

accord healthcare ireland ltd. - aripiprazole - tablet - 15 milligram(s) - other antipsychotics; aripiprazole

İrlanda - İngilizce - HPRA (Health Products Regulatory Authority)

accord healthcare ireland ltd. - aripiprazole - tablet - 30 milligram(s) - other antipsychotics; aripiprazole

İrlanda - İngilizce - HPRA (Health Products Regulatory Authority)

accord healthcare ireland ltd. - aripiprazole - tablet - 5 milligram(s) - other antipsychotics; aripiprazole